Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Jun 14, 2020 9:00 AM - Jun 18, 2020 5:00 PM

(Eastern Standard Time)

Fort Washington, PA 19034

DIA 2020 Global Annual Meeting

Patient Voice and its Role In Bringing Meaningfulness into Selection of Clinical Outcome Measures

Session Chair(s)

Alexander  Varond, JD

Alexander Varond, JD

Partner

Goodwin Procter LLP, United States

Patients are playing an increasing role in drug development. This session discusses on one area where this true -- in understanding clinical meaningfulness and selection and development of clinical outcome measures.

Learning Objective : Develop endpoints that capture individuals' most burdensome aspect of the disease; Identify the role of the patient voice in endpoint selection and assessment.

Speaker(s)

Patroula  Smpokou, MD

FDA Perspective

Patroula Smpokou, MD

FDA, United States

Lead Physician, Division of Rare Diseases/Medical Genetics, OND, CDER

Alison  Skrinar, PhD, MPH

Industry Perspective

Alison Skrinar, PhD, MPH

Ultragenyx Pharmaceutical, United States

Vice President, Clinical Outcomes Research and Evaluation

James  Valentine, JD, MHS

Patient Perspective

James Valentine, JD, MHS

Hyman, Phelps & McNamara, PC, United States

Director

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.